The IQVIA Institute for Human Data Science

Evidence-based insights for healthcare

The IQVIA Institute for Human Data Science contributes to the advancement of human health globally through timely research, insightful analysis and scientific expertise applied to granular non-identified patient-level data.
Subscribe to the IQVIA Institute
Be among the first to hear about research and activities

Latest Reports

Download the latest Institute reports

Institute Report

Modeling Policy Proposals for Medical Benefit Biosimilar Reimbursement in the U.S.

Institute Report

Global Medicine Use Trends 2026

Therapy drivers, spending levels, and policy evolution
Institute Report

Unlocking Biosimilar Potential

Ophthalmology Case Study

Institute Report

Impacts of the Proliferation of Innovation

Characterizing post-launch drug development, unmet need, and the potential implications of Medicare price negotiations
Institute Report

Digital Health Trends 2025

Business Models, Evidence Requirements, and Revenue Opportunities

Modeling Policy Proposals for Medical Benefit Biosimilar Reimbursement in the U.S.
Global Medicine Use Trends 2026
Unlocking Biosimilar Potential
Impacts of the Proliferation of Innovation
Digital Health Trends 2025
View all recent reports
Digital Health Trends 2025

Video

Digital Health Trends 2025

Digital health is entering a new phase in 2025, as stakeholders refine evidence standards, reimbursement pathways, and business models. This research brief highlights global policy shifts, U.S. billing trends, AI-enabled innovation, and the strategies shaping sustainable adoption.

Video

Global Medicine Use Trends 2026

Global medicine use and spending are entering a new phase shaped by health policy shifts, trade dynamics, and the continued adoption of innovation. By 2030, usage is projected to approach four trillion defined daily doses, with China driving much of the growth while mature markets stabilize. This video explores the outlook to 2030, highlighting the role of innovative therapies, evolving pricing dynamics, and the implications for patients and health systems worldwide.

Video

IQVIA Institute Year-in-Review 2025

From flagship trend reports and oncology research to webinars, public forums, and external engagement, the year reflects growing demand for evidence-based insights and human data science.

Institute Report

Digital Health Trends 2025

Business Models, Evidence Requirements, and Revenue Opportunities

Institute Report

Expanding Options for Emerging Biopharma in the U.S.: A Decade of Change

Over the past decade, emerging biopharma (EBP) companies have transformed the innovation landscape - originating nearly half of all new drug launches and driving advances in specialty, orphan, and first-in-class therapies. This IQVIA Institute report analyzes how EBPs are reshaping R&D productivity, funding models, and commercialization in the U.S. market, offering insights into their expanding role in delivering breakthrough treatments.

View all of the IQVIA Institute's Upcoming and On-Demand Events

Trending

Annual Reports on Latest Trends

The Global Use of Medicines

Learn about spending and usage of medicines in the past year and outlook to the future, globally and across specific therapy areas and countries.

Global Trends in R&D

Discover trends in drug approvals and launches, pipeline activity, and data on clinical trial activity.

The Use of Medicines in the U.S.

Examine the state of the U.S. health system, medicine usage, drug pricing, and costs for patients.

Global Oncology Trends

Explore research and development in oncology and the progress being made to improve representativeness of race and ethnicity in clinical trial populations.

Contact Us